Startups
Panome Bio can help you profile and discover biomarkers with our Next-Generation Metabolomics capabilities, comprehensive workflows and personalized data analysis reports. Our Next-Generation Metabolomics platform is making major advancements in the metabolism field by going beyond pairwise comparisons and making complex experiments with large and complicated datasets possible. Cutting-edge technology and computational methods are used to extract only the biologically-relevant chemical compounds to give you a clearer view of phenotype. We provide a global and unbiased view of the metabolome through a suite of complementary LC/MS assays that captures the breadth of diverse metabolites in biological systems. We have the ability to complement your metabolomics data with proteomics to better understand pathways and metabolism through our partnership with Somalogic. Somalogic’s SomaScan® 7K Assay is a high-throughput proteomics assay that screens 7,000 proteins per sample simultaneously.
Overview
Location
United States, Missouri, Saint Louis
Employees
1-10
Founded date
2022
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Panome Bio | “Discover and profile biomarkers with Next-Generation Metabolomics™. Panome Bio provides an unbiased and global view of metabolism through untargeted analysis and propietary computational methods.” | |
| Panome Bio | “Discover and profile biomarkers with Next-Generation Metabolomics™, lipidomics, and proteomics. Panome Bio provides an unbiased and global view of metabolism through untargeted analysis and propietary computational methods.” |
Reviews 0
FAQ about Panome Bio
When was Panome Bio founded?
Panome Bio was founded in 2022.
What has the press written about Panome Bio?
Parsers VC has collected 3 articles mentioning Panome Bio, among them “Panome Bio” and “Panome Bio”.
Is Panome Bio still active?
Panome Bio is probably closed: its latest activity on Parsers VC dates from Mar 15, 2023.